Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol “SLRX” – GlobeNewswire

Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following combination with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol “SLRX”  GlobeNewswire

Source: news.google.com